 CINCINNATI, Jan. 10, 2022 PRNewswire -- Meridian Bioscience, Inc. NASDAQ: VIVO, a leading global provider of diagnostic testing solutions and life science raw materials, will report first quarter 2022 financial results Friday, February 4, 2022. Jack Kenny, Chief Executive Officer, will host a conference call beginning at 10:00 a.m. 